However, TLR4 knockout mice completely lack an IL-6 response, and IL-6 may be a more promising therapeutic target for preventing or alleviating chemotherapy-induced gastrointestinal mucositis (Khan et al., 2018). Here, TLR4 is linked to gastrointestinal mucositis.